nodes	percent_of_prediction	percent_of_DWPC	metapath
Regorafenib—CYP2B6—Benzphetamine—obesity	0.0647	0.148	CbGbCtD
Regorafenib—CYP2B6—Bupropion—obesity	0.055	0.126	CbGbCtD
Regorafenib—CYP2C8—Bupropion—obesity	0.0417	0.0954	CbGbCtD
Regorafenib—CYP2C9—Phentermine—obesity	0.0342	0.0782	CbGbCtD
Regorafenib—CYP2C8—Cimetidine—obesity	0.0306	0.07	CbGbCtD
Regorafenib—CYP2C9—Bupropion—obesity	0.0291	0.0665	CbGbCtD
Regorafenib—CYP3A4—Sibutramine—obesity	0.0262	0.06	CbGbCtD
Regorafenib—CYP2C19—Cimetidine—obesity	0.0257	0.0587	CbGbCtD
Regorafenib—CYP2C9—Cimetidine—obesity	0.0213	0.0488	CbGbCtD
Regorafenib—ABCB1—Cimetidine—obesity	0.0207	0.0474	CbGbCtD
Regorafenib—CYP3A4—Benzphetamine—obesity	0.0199	0.0455	CbGbCtD
Regorafenib—CYP3A4—Bupropion—obesity	0.0169	0.0387	CbGbCtD
Regorafenib—CYP2C19—Topiramate—obesity	0.0168	0.0384	CbGbCtD
Regorafenib—CYP3A4—Orlistat—obesity	0.0138	0.0315	CbGbCtD
Regorafenib—CYP3A4—Cimetidine—obesity	0.0124	0.0284	CbGbCtD
Regorafenib—CYP3A4—Topiramate—obesity	0.00812	0.0186	CbGbCtD
Regorafenib—International normalised ratio increased—Orlistat—obesity	0.00739	0.047	CcSEcCtD
Regorafenib—Traumatic liver injury—Cimetidine—obesity	0.00556	0.0354	CcSEcCtD
Regorafenib—RET—autonomic nervous system—obesity	0.00494	0.0367	CbGeAlD
Regorafenib—Liver injury—Phenylpropanolamine—obesity	0.00311	0.0198	CcSEcCtD
Regorafenib—Hepatotoxicity—Cimetidine—obesity	0.00268	0.0171	CcSEcCtD
Regorafenib—Liver injury—Cimetidine—obesity	0.00246	0.0157	CcSEcCtD
Regorafenib—DDR2—respiratory system—obesity	0.00236	0.0176	CbGeAlD
Regorafenib—DDR2—adrenal cortex—obesity	0.00198	0.0147	CbGeAlD
Regorafenib—FGFR2—hindbrain—obesity	0.00198	0.0147	CbGeAlD
Regorafenib—RAF1—hindbrain—obesity	0.00182	0.0135	CbGeAlD
Regorafenib—DDR2—cardiovascular system—obesity	0.00181	0.0134	CbGeAlD
Regorafenib—Hypothyroidism—Orlistat—obesity	0.00178	0.0113	CcSEcCtD
Regorafenib—Nail disorder—Orlistat—obesity	0.00176	0.0112	CcSEcCtD
Regorafenib—Hypothyroidism—Sibutramine—obesity	0.00172	0.011	CcSEcCtD
Regorafenib—Nail disorder—Sibutramine—obesity	0.00171	0.0109	CcSEcCtD
Regorafenib—PDGFRA—gall bladder—obesity	0.00169	0.0126	CbGeAlD
Regorafenib—DDR2—pituitary gland—obesity	0.0016	0.0119	CbGeAlD
Regorafenib—DDR2—adipose tissue—obesity	0.0016	0.0119	CbGeAlD
Regorafenib—Polyp—Bupropion—obesity	0.00159	0.0101	CcSEcCtD
Regorafenib—MAPK11—adipose tissue—obesity	0.00151	0.0112	CbGeAlD
Regorafenib—DDR2—digestive system—obesity	0.0015	0.0112	CbGeAlD
Regorafenib—Cyst—Bupropion—obesity	0.00144	0.00918	CcSEcCtD
Regorafenib—FLT4—respiratory system—obesity	0.00144	0.0107	CbGeAlD
Regorafenib—DDR2—adrenal gland—obesity	0.00143	0.0106	CbGeAlD
Regorafenib—Tremor—Methamphetamine—obesity	0.00143	0.00908	CcSEcCtD
Regorafenib—FRK—endocrine gland—obesity	0.00138	0.0103	CbGeAlD
Regorafenib—Acute coronary syndrome—Phentermine—obesity	0.00138	0.00878	CcSEcCtD
Regorafenib—Tremor—Benzphetamine—obesity	0.00138	0.00875	CcSEcCtD
Regorafenib—KIT—hindbrain—obesity	0.00137	0.0102	CbGeAlD
Regorafenib—Myocardial infarction—Phentermine—obesity	0.00137	0.00873	CcSEcCtD
Regorafenib—MAPK11—adrenal gland—obesity	0.00136	0.0101	CbGeAlD
Regorafenib—KIT—gall bladder—obesity	0.00135	0.0101	CbGeAlD
Regorafenib—Toxic epidermal necrolysis—Cimetidine—obesity	0.00135	0.00861	CcSEcCtD
Regorafenib—EPHX2—adrenal cortex—obesity	0.00134	0.00995	CbGeAlD
Regorafenib—PDGFRB—gall bladder—obesity	0.00132	0.00983	CbGeAlD
Regorafenib—EPHA2—islet of Langerhans—obesity	0.00126	0.00934	CbGeAlD
Regorafenib—Tremor—Phendimetrazine—obesity	0.00125	0.00798	CcSEcCtD
Regorafenib—Hepatotoxicity—Bupropion—obesity	0.00125	0.00795	CcSEcCtD
Regorafenib—FRK—liver—obesity	0.00125	0.00927	CbGeAlD
Regorafenib—DDR2—endocrine gland—obesity	0.00124	0.00922	CbGeAlD
Regorafenib—Hyperbilirubinaemia—Sibutramine—obesity	0.00122	0.00774	CcSEcCtD
Regorafenib—Neutropenia—Cimetidine—obesity	0.00121	0.00773	CcSEcCtD
Regorafenib—FLT4—adrenal cortex—obesity	0.00121	0.00897	CbGeAlD
Regorafenib—FGFR2—respiratory system—obesity	0.00121	0.00897	CbGeAlD
Regorafenib—Lymphopenia—Topiramate—obesity	0.0012	0.00764	CcSEcCtD
Regorafenib—ABL1—hindbrain—obesity	0.00119	0.00888	CbGeAlD
Regorafenib—Hyperuricaemia—Sibutramine—obesity	0.00119	0.00759	CcSEcCtD
Regorafenib—EPHA2—respiratory system—obesity	0.00119	0.00882	CbGeAlD
Regorafenib—FLT1—islet of Langerhans—obesity	0.00119	0.00881	CbGeAlD
Regorafenib—RAF1—islet of Langerhans—obesity	0.00118	0.00875	CbGeAlD
Regorafenib—TEK—respiratory system—obesity	0.00116	0.0086	CbGeAlD
Regorafenib—Stevens-Johnson syndrome—Cimetidine—obesity	0.00115	0.00731	CcSEcCtD
Regorafenib—Liver injury—Bupropion—obesity	0.00115	0.00729	CcSEcCtD
Regorafenib—BRAF—pituitary gland—obesity	0.00113	0.00841	CbGeAlD
Regorafenib—BRAF—adipose tissue—obesity	0.00113	0.00838	CbGeAlD
Regorafenib—Blood uric acid increased—Sibutramine—obesity	0.00113	0.00717	CcSEcCtD
Regorafenib—FLT1—respiratory system—obesity	0.00112	0.00831	CbGeAlD
Regorafenib—DDR2—liver—obesity	0.00112	0.00831	CbGeAlD
Regorafenib—RAF1—respiratory system—obesity	0.00111	0.00827	CbGeAlD
Regorafenib—FLT4—cardiovascular system—obesity	0.0011	0.00819	CbGeAlD
Regorafenib—EPHX2—pituitary gland—obesity	0.00108	0.00804	CbGeAlD
Regorafenib—EPHX2—adipose tissue—obesity	0.00108	0.00801	CbGeAlD
Regorafenib—Musculoskeletal stiffness—Bupropion—obesity	0.00108	0.00684	CcSEcCtD
Regorafenib—Gastrointestinal disorder—Methamphetamine—obesity	0.00107	0.00683	CcSEcCtD
Regorafenib—Tremor—Phenylpropanolamine—obesity	0.00107	0.00681	CcSEcCtD
Regorafenib—Gastrooesophageal reflux disease—Bupropion—obesity	0.00107	0.0068	CcSEcCtD
Regorafenib—Hypophosphataemia—Topiramate—obesity	0.00106	0.00673	CcSEcCtD
Regorafenib—PDGFRA—respiratory system—obesity	0.00105	0.00779	CbGeAlD
Regorafenib—Decreased appetite—Benzphetamine—obesity	0.00104	0.00663	CcSEcCtD
Regorafenib—Gastrointestinal disorder—Benzphetamine—obesity	0.00103	0.00658	CcSEcCtD
Regorafenib—Neoplasm—Orlistat—obesity	0.00103	0.00658	CcSEcCtD
Regorafenib—Tremor—Phentermine—obesity	0.00102	0.00652	CcSEcCtD
Regorafenib—BRAF—adrenal gland—obesity	0.00101	0.00752	CbGeAlD
Regorafenib—Neoplasm—Sibutramine—obesity	0.001	0.00637	CcSEcCtD
Regorafenib—EPHA2—adrenal cortex—obesity	0.000996	0.0074	CbGeAlD
Regorafenib—Erythema multiforme—Cimetidine—obesity	0.000983	0.00626	CcSEcCtD
Regorafenib—FLT4—adipose tissue—obesity	0.000972	0.00722	CbGeAlD
Regorafenib—TEK—adrenal cortex—obesity	0.000971	0.00722	CbGeAlD
Regorafenib—EPHX2—adrenal gland—obesity	0.000967	0.00718	CbGeAlD
Regorafenib—Alopecia—Diethylpropion—obesity	0.000966	0.00615	CcSEcCtD
Regorafenib—FGFR1—pituitary gland—obesity	0.000963	0.00715	CbGeAlD
Regorafenib—FGFR1—adipose tissue—obesity	0.000959	0.00712	CbGeAlD
Regorafenib—Decreased appetite—Phendimetrazine—obesity	0.000949	0.00604	CcSEcCtD
Regorafenib—Nail disorder—Topiramate—obesity	0.000948	0.00603	CcSEcCtD
Regorafenib—KDR—respiratory system—obesity	0.000946	0.00703	CbGeAlD
Regorafenib—Hypertension—Phentermine—obesity	0.000944	0.00601	CcSEcCtD
Regorafenib—FLT1—adrenal cortex—obesity	0.000939	0.00698	CbGeAlD
Regorafenib—RAF1—adrenal cortex—obesity	0.000934	0.00694	CbGeAlD
Regorafenib—UGT1A9—digestive system—obesity	0.000928	0.00689	CbGeAlD
Regorafenib—FGFR2—cardiovascular system—obesity	0.000925	0.00687	CbGeAlD
Regorafenib—Alopecia—Cimetidine—obesity	0.000919	0.00585	CcSEcCtD
Regorafenib—Dry mouth—Phentermine—obesity	0.000911	0.00579	CcSEcCtD
Regorafenib—EPHA2—cardiovascular system—obesity	0.000909	0.00675	CbGeAlD
Regorafenib—Gastroenteritis—Sibutramine—obesity	0.000906	0.00577	CcSEcCtD
Regorafenib—Tremor—Diethylpropion—obesity	0.000891	0.00567	CcSEcCtD
Regorafenib—TEK—cardiovascular system—obesity	0.000887	0.00659	CbGeAlD
Regorafenib—Neoplasm—Bupropion—obesity	0.000872	0.00555	CcSEcCtD
Regorafenib—FLT4—adrenal gland—obesity	0.000872	0.00648	CbGeAlD
Regorafenib—PDGFRB—islet of Langerhans—obesity	0.000867	0.00644	CbGeAlD
Regorafenib—Abdominal pain—Phendimetrazine—obesity	0.000863	0.00549	CcSEcCtD
Regorafenib—RET—pituitary gland—obesity	0.000862	0.0064	CbGeAlD
Regorafenib—FGFR1—adrenal gland—obesity	0.00086	0.00639	CbGeAlD
Regorafenib—FLT1—cardiovascular system—obesity	0.000857	0.00637	CbGeAlD
Regorafenib—RAF1—cardiovascular system—obesity	0.000852	0.00633	CbGeAlD
Regorafenib—Leukopenia—Diethylpropion—obesity	0.000852	0.00542	CcSEcCtD
Regorafenib—Diarrhoea—Methamphetamine—obesity	0.00085	0.00541	CcSEcCtD
Regorafenib—KIT—respiratory system—obesity	0.000838	0.00623	CbGeAlD
Regorafenib—Diarrhoea—Benzphetamine—obesity	0.00082	0.00522	CcSEcCtD
Regorafenib—PDGFRB—respiratory system—obesity	0.000819	0.00608	CbGeAlD
Regorafenib—FGFR2—adipose tissue—obesity	0.000815	0.00606	CbGeAlD
Regorafenib—Leukopenia—Cimetidine—obesity	0.00081	0.00516	CcSEcCtD
Regorafenib—RET—digestive system—obesity	0.000808	0.006	CbGeAlD
Regorafenib—EPHA2—pituitary gland—obesity	0.000805	0.00598	CbGeAlD
Regorafenib—PDGFRA—cardiovascular system—obesity	0.000803	0.00597	CbGeAlD
Regorafenib—EPHA2—adipose tissue—obesity	0.000801	0.00595	CbGeAlD
Regorafenib—KDR—adrenal cortex—obesity	0.000794	0.0059	CbGeAlD
Regorafenib—Dry mouth—Diethylpropion—obesity	0.000792	0.00504	CcSEcCtD
Regorafenib—BRAF—liver—obesity	0.000791	0.00588	CbGeAlD
Regorafenib—Gastroenteritis—Bupropion—obesity	0.00079	0.00503	CcSEcCtD
Regorafenib—TEK—pituitary gland—obesity	0.000785	0.00583	CbGeAlD
Regorafenib—TEK—adipose tissue—obesity	0.000782	0.00581	CbGeAlD
Regorafenib—Headache—Methamphetamine—obesity	0.000778	0.00495	CcSEcCtD
Regorafenib—ABL1—islet of Langerhans—obesity	0.000773	0.00574	CbGeAlD
Regorafenib—Gastrointestinal disorder—Phentermine—obesity	0.000771	0.0049	CcSEcCtD
Regorafenib—RET—adrenal gland—obesity	0.00077	0.00572	CbGeAlD
Regorafenib—Fatigue—Phentermine—obesity	0.00077	0.0049	CcSEcCtD
Regorafenib—FGFR2—digestive system—obesity	0.000768	0.0057	CbGeAlD
Regorafenib—UGT1A9—endocrine gland—obesity	0.000767	0.0057	CbGeAlD
Regorafenib—Dry skin—Orlistat—obesity	0.000761	0.00484	CcSEcCtD
Regorafenib—FLT1—pituitary gland—obesity	0.000759	0.00564	CbGeAlD
Regorafenib—FLT4—endocrine gland—obesity	0.000756	0.00562	CbGeAlD
Regorafenib—EPHX2—liver—obesity	0.000756	0.00562	CbGeAlD
Regorafenib—FLT1—adipose tissue—obesity	0.000756	0.00562	CbGeAlD
Regorafenib—Hypokalaemia—Orlistat—obesity	0.000755	0.00481	CcSEcCtD
Regorafenib—Sorafenib—HTR2C—obesity	0.000755	1	CrCbGaD
Regorafenib—RAF1—pituitary gland—obesity	0.000754	0.00561	CbGeAlD
Regorafenib—EPHA2—digestive system—obesity	0.000754	0.0056	CbGeAlD
Regorafenib—RAF1—adipose tissue—obesity	0.000751	0.00558	CbGeAlD
Regorafenib—Headache—Benzphetamine—obesity	0.00075	0.00478	CcSEcCtD
Regorafenib—Diarrhoea—Phendimetrazine—obesity	0.000747	0.00475	CcSEcCtD
Regorafenib—Dysphonia—Topiramate—obesity	0.000747	0.00475	CcSEcCtD
Regorafenib—Endocrine disorder—Topiramate—obesity	0.000741	0.00472	CcSEcCtD
Regorafenib—Dry skin—Sibutramine—obesity	0.000736	0.00469	CcSEcCtD
Regorafenib—FGFR2—adrenal gland—obesity	0.000731	0.00543	CbGeAlD
Regorafenib—Hypokalaemia—Sibutramine—obesity	0.000731	0.00465	CcSEcCtD
Regorafenib—ABL1—respiratory system—obesity	0.00073	0.00542	CbGeAlD
Regorafenib—KDR—cardiovascular system—obesity	0.000725	0.00538	CbGeAlD
Regorafenib—Thrombocytopenia—Cimetidine—obesity	0.000723	0.0046	CcSEcCtD
Regorafenib—Aspartate aminotransferase increased—Sibutramine—obesity	0.000723	0.0046	CcSEcCtD
Regorafenib—EPHA2—adrenal gland—obesity	0.000719	0.00534	CbGeAlD
Regorafenib—Nausea—Benzphetamine—obesity	0.000712	0.00453	CcSEcCtD
Regorafenib—FLT1—digestive system—obesity	0.000711	0.00529	CbGeAlD
Regorafenib—Alanine aminotransferase increased—Sibutramine—obesity	0.000708	0.00451	CcSEcCtD
Regorafenib—PDGFRA—adipose tissue—obesity	0.000708	0.00526	CbGeAlD
Regorafenib—RAF1—digestive system—obesity	0.000707	0.00526	CbGeAlD
Regorafenib—Abdominal pain—Phentermine—obesity	0.000706	0.00449	CcSEcCtD
Regorafenib—TEK—adrenal gland—obesity	0.000701	0.00521	CbGeAlD
Regorafenib—UGT1A9—liver—obesity	0.000691	0.00514	CbGeAlD
Regorafenib—PDGFRB—adrenal cortex—obesity	0.000687	0.00511	CbGeAlD
Regorafenib—Musculoskeletal stiffness—Topiramate—obesity	0.000685	0.00436	CcSEcCtD
Regorafenib—Headache—Phendimetrazine—obesity	0.000684	0.00435	CcSEcCtD
Regorafenib—FLT4—liver—obesity	0.000682	0.00506	CbGeAlD
Regorafenib—Gastrooesophageal reflux disease—Topiramate—obesity	0.00068	0.00433	CcSEcCtD
Regorafenib—FLT1—adrenal gland—obesity	0.000678	0.00504	CbGeAlD
Regorafenib—RAF1—adrenal gland—obesity	0.000674	0.00501	CbGeAlD
Regorafenib—FGFR1—liver—obesity	0.000673	0.005	CbGeAlD
Regorafenib—Hypocalcaemia—Topiramate—obesity	0.000671	0.00427	CcSEcCtD
Regorafenib—Gastrointestinal disorder—Diethylpropion—obesity	0.00067	0.00427	CcSEcCtD
Regorafenib—RET—endocrine gland—obesity	0.000668	0.00496	CbGeAlD
Regorafenib—PDGFRA—digestive system—obesity	0.000667	0.00495	CbGeAlD
Regorafenib—Nausea—Phendimetrazine—obesity	0.000649	0.00413	CcSEcCtD
Regorafenib—KIT—cardiovascular system—obesity	0.000642	0.00477	CbGeAlD
Regorafenib—Dry skin—Bupropion—obesity	0.000642	0.00408	CcSEcCtD
Regorafenib—KDR—pituitary gland—obesity	0.000642	0.00477	CbGeAlD
Regorafenib—Asthenia—Phentermine—obesity	0.00064	0.00408	CcSEcCtD
Regorafenib—Infestation—Orlistat—obesity	0.00064	0.00407	CcSEcCtD
Regorafenib—Infestation NOS—Orlistat—obesity	0.00064	0.00407	CcSEcCtD
Regorafenib—KDR—adipose tissue—obesity	0.000639	0.00475	CbGeAlD
Regorafenib—Fatigue—Cimetidine—obesity	0.000637	0.00405	CcSEcCtD
Regorafenib—UGT1A1—digestive system—obesity	0.000636	0.00473	CbGeAlD
Regorafenib—PDGFRA—adrenal gland—obesity	0.000635	0.00472	CbGeAlD
Regorafenib—FGFR2—endocrine gland—obesity	0.000634	0.00471	CbGeAlD
Regorafenib—PDGFRB—cardiovascular system—obesity	0.000627	0.00466	CbGeAlD
Regorafenib—EPHA2—endocrine gland—obesity	0.000623	0.00463	CbGeAlD
Regorafenib—ABL1—adrenal cortex—obesity	0.000612	0.00455	CbGeAlD
Regorafenib—Diarrhoea—Phentermine—obesity	0.000611	0.00389	CcSEcCtD
Regorafenib—Acute coronary syndrome—Sibutramine—obesity	0.00061	0.00388	CcSEcCtD
Regorafenib—TEK—endocrine gland—obesity	0.000608	0.00452	CbGeAlD
Regorafenib—Myocardial infarction—Sibutramine—obesity	0.000607	0.00386	CcSEcCtD
Regorafenib—Hepatobiliary disease—Orlistat—obesity	0.000605	0.00385	CcSEcCtD
Regorafenib—Stomatitis—Sibutramine—obesity	0.000603	0.00384	CcSEcCtD
Regorafenib—KDR—digestive system—obesity	0.000601	0.00447	CbGeAlD
Regorafenib—Vomiting—Phenylpropanolamine—obesity	0.000593	0.00377	CcSEcCtD
Regorafenib—Rash—Phenylpropanolamine—obesity	0.000588	0.00374	CcSEcCtD
Regorafenib—FLT1—endocrine gland—obesity	0.000588	0.00437	CbGeAlD
Regorafenib—Dermatitis—Phenylpropanolamine—obesity	0.000588	0.00374	CcSEcCtD
Regorafenib—RAF1—endocrine gland—obesity	0.000584	0.00434	CbGeAlD
Regorafenib—Body temperature increased—Cimetidine—obesity	0.000584	0.00372	CcSEcCtD
Regorafenib—Haemoglobin—Orlistat—obesity	0.000577	0.00367	CcSEcCtD
Regorafenib—Haemorrhage—Orlistat—obesity	0.000574	0.00365	CcSEcCtD
Regorafenib—KDR—adrenal gland—obesity	0.000573	0.00426	CbGeAlD
Regorafenib—FGFR2—liver—obesity	0.000572	0.00425	CbGeAlD
Regorafenib—KIT—pituitary gland—obesity	0.000569	0.00422	CbGeAlD
Regorafenib—Vomiting—Phentermine—obesity	0.000568	0.00361	CcSEcCtD
Regorafenib—Urinary tract disorder—Orlistat—obesity	0.000567	0.00361	CcSEcCtD
Regorafenib—KIT—adipose tissue—obesity	0.000566	0.00421	CbGeAlD
Regorafenib—Urethral disorder—Orlistat—obesity	0.000563	0.00358	CcSEcCtD
Regorafenib—Rash—Phentermine—obesity	0.000563	0.00358	CcSEcCtD
Regorafenib—Dermatitis—Phentermine—obesity	0.000562	0.00358	CcSEcCtD
Regorafenib—EPHA2—liver—obesity	0.000562	0.00418	CbGeAlD
Regorafenib—Headache—Phentermine—obesity	0.000559	0.00356	CcSEcCtD
Regorafenib—ABL1—cardiovascular system—obesity	0.000559	0.00415	CbGeAlD
Regorafenib—Haemoglobin—Sibutramine—obesity	0.000558	0.00355	CcSEcCtD
Regorafenib—Haemorrhage—Sibutramine—obesity	0.000556	0.00354	CcSEcCtD
Regorafenib—Neoplasm—Topiramate—obesity	0.000556	0.00354	CcSEcCtD
Regorafenib—PDGFRB—pituitary gland—obesity	0.000555	0.00413	CbGeAlD
Regorafenib—Nausea—Phenylpropanolamine—obesity	0.000554	0.00353	CcSEcCtD
Regorafenib—PDGFRB—adipose tissue—obesity	0.000553	0.00411	CbGeAlD
Regorafenib—PDGFRA—endocrine gland—obesity	0.000551	0.00409	CbGeAlD
Regorafenib—TEK—liver—obesity	0.000548	0.00407	CbGeAlD
Regorafenib—Weight decreased—Bupropion—obesity	0.000548	0.00348	CcSEcCtD
Regorafenib—Infestation NOS—Bupropion—obesity	0.00054	0.00343	CcSEcCtD
Regorafenib—Infestation—Bupropion—obesity	0.00054	0.00343	CcSEcCtD
Regorafenib—Stevens-Johnson syndrome—Bupropion—obesity	0.000535	0.0034	CcSEcCtD
Regorafenib—KIT—digestive system—obesity	0.000533	0.00396	CbGeAlD
Regorafenib—Acute coronary syndrome—Bupropion—obesity	0.000532	0.00339	CcSEcCtD
Regorafenib—Diarrhoea—Diethylpropion—obesity	0.000531	0.00338	CcSEcCtD
Regorafenib—Nausea—Phentermine—obesity	0.00053	0.00337	CcSEcCtD
Regorafenib—Asthenia—Cimetidine—obesity	0.00053	0.00337	CcSEcCtD
Regorafenib—FLT1—liver—obesity	0.00053	0.00394	CbGeAlD
Regorafenib—Myocardial infarction—Bupropion—obesity	0.000529	0.00337	CcSEcCtD
Regorafenib—RAF1—liver—obesity	0.000527	0.00392	CbGeAlD
Regorafenib—Stomatitis—Bupropion—obesity	0.000526	0.00335	CcSEcCtD
Regorafenib—UGT1A1—endocrine gland—obesity	0.000526	0.0039	CbGeAlD
Regorafenib—PDGFRB—digestive system—obesity	0.000521	0.00387	CbGeAlD
Regorafenib—Mediastinal disorder—Orlistat—obesity	0.000517	0.00329	CcSEcCtD
Regorafenib—KIT—adrenal gland—obesity	0.000508	0.00377	CbGeAlD
Regorafenib—Alopecia—Orlistat—obesity	0.000507	0.00323	CcSEcCtD
Regorafenib—Diarrhoea—Cimetidine—obesity	0.000506	0.00322	CcSEcCtD
Regorafenib—Angiopathy—Sibutramine—obesity	0.000504	0.00321	CcSEcCtD
Regorafenib—Gastroenteritis—Topiramate—obesity	0.000503	0.0032	CcSEcCtD
Regorafenib—Malnutrition—Orlistat—obesity	0.0005	0.00318	CcSEcCtD
Regorafenib—KDR—endocrine gland—obesity	0.000497	0.00369	CbGeAlD
Regorafenib—PDGFRA—liver—obesity	0.000497	0.00369	CbGeAlD
Regorafenib—PDGFRB—adrenal gland—obesity	0.000496	0.00369	CbGeAlD
Regorafenib—ABL1—pituitary gland—obesity	0.000495	0.00368	CbGeAlD
Regorafenib—Vomiting—Diethylpropion—obesity	0.000494	0.00314	CcSEcCtD
Regorafenib—ABL1—adipose tissue—obesity	0.000493	0.00366	CbGeAlD
Regorafenib—Alopecia—Sibutramine—obesity	0.000491	0.00312	CcSEcCtD
Regorafenib—Rash—Diethylpropion—obesity	0.00049	0.00312	CcSEcCtD
Regorafenib—Dermatitis—Diethylpropion—obesity	0.000489	0.00311	CcSEcCtD
Regorafenib—Haemoglobin—Bupropion—obesity	0.000487	0.0031	CcSEcCtD
Regorafenib—Headache—Diethylpropion—obesity	0.000486	0.0031	CcSEcCtD
Regorafenib—Haemorrhage—Bupropion—obesity	0.000484	0.00308	CcSEcCtD
Regorafenib—Malnutrition—Sibutramine—obesity	0.000484	0.00308	CcSEcCtD
Regorafenib—Urinary tract disorder—Bupropion—obesity	0.000478	0.00304	CcSEcCtD
Regorafenib—Connective tissue disorder—Bupropion—obesity	0.000476	0.00303	CcSEcCtD
Regorafenib—Urethral disorder—Bupropion—obesity	0.000475	0.00302	CcSEcCtD
Regorafenib—UGT1A1—liver—obesity	0.000474	0.00352	CbGeAlD
Regorafenib—Vomiting—Cimetidine—obesity	0.00047	0.00299	CcSEcCtD
Regorafenib—Rash—Cimetidine—obesity	0.000466	0.00296	CcSEcCtD
Regorafenib—Dermatitis—Cimetidine—obesity	0.000465	0.00296	CcSEcCtD
Regorafenib—ABL1—digestive system—obesity	0.000464	0.00345	CbGeAlD
Regorafenib—Headache—Cimetidine—obesity	0.000463	0.00295	CcSEcCtD
Regorafenib—Nausea—Diethylpropion—obesity	0.000461	0.00294	CcSEcCtD
Regorafenib—Erythema multiforme—Bupropion—obesity	0.000458	0.00291	CcSEcCtD
Regorafenib—Tremor—Sibutramine—obesity	0.000453	0.00288	CcSEcCtD
Regorafenib—Cardiac disorder—Bupropion—obesity	0.00045	0.00286	CcSEcCtD
Regorafenib—KDR—liver—obesity	0.000448	0.00333	CbGeAlD
Regorafenib—Hyponatraemia—Topiramate—obesity	0.000448	0.00285	CcSEcCtD
Regorafenib—Anaemia—Sibutramine—obesity	0.000447	0.00284	CcSEcCtD
Regorafenib—ABL1—adrenal gland—obesity	0.000442	0.00328	CbGeAlD
Regorafenib—KIT—endocrine gland—obesity	0.00044	0.00327	CbGeAlD
Regorafenib—Angiopathy—Bupropion—obesity	0.000439	0.0028	CcSEcCtD
Regorafenib—Nausea—Cimetidine—obesity	0.000439	0.00279	CcSEcCtD
Regorafenib—Mediastinal disorder—Bupropion—obesity	0.000437	0.00278	CcSEcCtD
Regorafenib—Leukopenia—Sibutramine—obesity	0.000433	0.00276	CcSEcCtD
Regorafenib—PDGFRB—endocrine gland—obesity	0.00043	0.0032	CbGeAlD
Regorafenib—Alopecia—Bupropion—obesity	0.000428	0.00272	CcSEcCtD
Regorafenib—CYP2B6—respiratory system—obesity	0.000425	0.00315	CbGeAlD
Regorafenib—Unspecified disorder of skin and subcutaneous tissue—Orlistat—obesity	0.000423	0.00269	CcSEcCtD
Regorafenib—Malnutrition—Bupropion—obesity	0.000422	0.00268	CcSEcCtD
Regorafenib—Hypertension—Sibutramine—obesity	0.000418	0.00266	CcSEcCtD
Regorafenib—Dry mouth—Orlistat—obesity	0.000416	0.00265	CcSEcCtD
Regorafenib—Hypokalaemia—Topiramate—obesity	0.000406	0.00258	CcSEcCtD
Regorafenib—Infection—Orlistat—obesity	0.000405	0.00258	CcSEcCtD
Regorafenib—Dry mouth—Sibutramine—obesity	0.000403	0.00256	CcSEcCtD
Regorafenib—Toxic epidermal necrolysis—Topiramate—obesity	0.000402	0.00256	CcSEcCtD
Regorafenib—Aspartate aminotransferase increased—Topiramate—obesity	0.000402	0.00256	CcSEcCtD
Regorafenib—Nervous system disorder—Orlistat—obesity	0.0004	0.00255	CcSEcCtD
Regorafenib—KIT—liver—obesity	0.000397	0.00295	CbGeAlD
Regorafenib—Skin disorder—Orlistat—obesity	0.000396	0.00252	CcSEcCtD
Regorafenib—Tremor—Bupropion—obesity	0.000395	0.00251	CcSEcCtD
Regorafenib—Alanine aminotransferase increased—Topiramate—obesity	0.000393	0.0025	CcSEcCtD
Regorafenib—Infection—Sibutramine—obesity	0.000392	0.0025	CcSEcCtD
Regorafenib—Anaemia—Bupropion—obesity	0.00039	0.00248	CcSEcCtD
Regorafenib—PDGFRB—liver—obesity	0.000388	0.00288	CbGeAlD
Regorafenib—Thrombocytopenia—Sibutramine—obesity	0.000387	0.00246	CcSEcCtD
Regorafenib—ABCG2—adrenal cortex—obesity	0.000386	0.00287	CbGeAlD
Regorafenib—Skin disorder—Sibutramine—obesity	0.000383	0.00244	CcSEcCtD
Regorafenib—ABL1—endocrine gland—obesity	0.000383	0.00285	CbGeAlD
Regorafenib—Leukopenia—Bupropion—obesity	0.000377	0.0024	CcSEcCtD
Regorafenib—Hypertension—Bupropion—obesity	0.000364	0.00232	CcSEcCtD
Regorafenib—Neutropenia—Topiramate—obesity	0.000361	0.00229	CcSEcCtD
Regorafenib—Unspecified disorder of skin and subcutaneous tissue—Bupropion—obesity	0.000357	0.00227	CcSEcCtD
Regorafenib—CYP2B6—adrenal cortex—obesity	0.000356	0.00265	CbGeAlD
Regorafenib—Decreased appetite—Orlistat—obesity	0.000355	0.00226	CcSEcCtD
Regorafenib—Gastrointestinal disorder—Orlistat—obesity	0.000352	0.00224	CcSEcCtD
Regorafenib—Fatigue—Orlistat—obesity	0.000352	0.00224	CcSEcCtD
Regorafenib—Dry mouth—Bupropion—obesity	0.000351	0.00223	CcSEcCtD
Regorafenib—Weight decreased—Topiramate—obesity	0.000349	0.00222	CcSEcCtD
Regorafenib—Pain—Orlistat—obesity	0.000349	0.00222	CcSEcCtD
Regorafenib—ABL1—liver—obesity	0.000346	0.00257	CbGeAlD
Regorafenib—CYP2C19—digestive system—obesity	0.000345	0.00256	CbGeAlD
Regorafenib—Infestation—Topiramate—obesity	0.000344	0.00219	CcSEcCtD
Regorafenib—Infestation NOS—Topiramate—obesity	0.000344	0.00219	CcSEcCtD
Regorafenib—Decreased appetite—Sibutramine—obesity	0.000343	0.00218	CcSEcCtD
Regorafenib—Infection—Bupropion—obesity	0.000342	0.00218	CcSEcCtD
Regorafenib—Stevens-Johnson syndrome—Topiramate—obesity	0.000341	0.00217	CcSEcCtD
Regorafenib—Gastrointestinal disorder—Sibutramine—obesity	0.000341	0.00217	CcSEcCtD
Regorafenib—Pain—Sibutramine—obesity	0.000338	0.00215	CcSEcCtD
Regorafenib—Nervous system disorder—Bupropion—obesity	0.000337	0.00215	CcSEcCtD
Regorafenib—Thrombocytopenia—Bupropion—obesity	0.000337	0.00214	CcSEcCtD
Regorafenib—Stomatitis—Topiramate—obesity	0.000335	0.00213	CcSEcCtD
Regorafenib—Skin disorder—Bupropion—obesity	0.000334	0.00213	CcSEcCtD
Regorafenib—Gastrointestinal pain—Orlistat—obesity	0.000334	0.00212	CcSEcCtD
Regorafenib—CYP2B6—cardiovascular system—obesity	0.000325	0.00242	CbGeAlD
Regorafenib—Gastrointestinal pain—Sibutramine—obesity	0.000323	0.00205	CcSEcCtD
Regorafenib—Abdominal pain—Orlistat—obesity	0.000322	0.00205	CcSEcCtD
Regorafenib—Body temperature increased—Orlistat—obesity	0.000322	0.00205	CcSEcCtD
Regorafenib—CYP2C9—cardiovascular system—obesity	0.000322	0.00239	CbGeAlD
Regorafenib—CYP2C8—pituitary gland—obesity	0.000321	0.00238	CbGeAlD
Regorafenib—ABCG2—pituitary gland—obesity	0.000312	0.00232	CbGeAlD
Regorafenib—Abdominal pain—Sibutramine—obesity	0.000312	0.00199	CcSEcCtD
Regorafenib—Body temperature increased—Sibutramine—obesity	0.000312	0.00199	CcSEcCtD
Regorafenib—ABCG2—adipose tissue—obesity	0.000311	0.00231	CbGeAlD
Regorafenib—Haemoglobin—Topiramate—obesity	0.00031	0.00197	CcSEcCtD
Regorafenib—Haemorrhage—Topiramate—obesity	0.000309	0.00196	CcSEcCtD
Regorafenib—Urinary tract disorder—Topiramate—obesity	0.000305	0.00194	CcSEcCtD
Regorafenib—Connective tissue disorder—Topiramate—obesity	0.000303	0.00193	CcSEcCtD
Regorafenib—Urethral disorder—Topiramate—obesity	0.000303	0.00193	CcSEcCtD
Regorafenib—Decreased appetite—Bupropion—obesity	0.000299	0.0019	CcSEcCtD
Regorafenib—Gastrointestinal disorder—Bupropion—obesity	0.000297	0.00189	CcSEcCtD
Regorafenib—Fatigue—Bupropion—obesity	0.000297	0.00189	CcSEcCtD
Regorafenib—Pain—Bupropion—obesity	0.000294	0.00187	CcSEcCtD
Regorafenib—Asthenia—Orlistat—obesity	0.000293	0.00186	CcSEcCtD
Regorafenib—Erythema multiforme—Topiramate—obesity	0.000292	0.00186	CcSEcCtD
Regorafenib—Cardiac disorder—Topiramate—obesity	0.000286	0.00182	CcSEcCtD
Regorafenib—CYP2C19—endocrine gland—obesity	0.000285	0.00212	CbGeAlD
Regorafenib—Asthenia—Sibutramine—obesity	0.000283	0.0018	CcSEcCtD
Regorafenib—Gastrointestinal pain—Bupropion—obesity	0.000281	0.00179	CcSEcCtD
Regorafenib—Angiopathy—Topiramate—obesity	0.00028	0.00178	CcSEcCtD
Regorafenib—Diarrhoea—Orlistat—obesity	0.000279	0.00178	CcSEcCtD
Regorafenib—ABCG2—adrenal gland—obesity	0.000279	0.00207	CbGeAlD
Regorafenib—Mediastinal disorder—Topiramate—obesity	0.000278	0.00177	CcSEcCtD
Regorafenib—Alopecia—Topiramate—obesity	0.000273	0.00174	CcSEcCtD
Regorafenib—Body temperature increased—Bupropion—obesity	0.000272	0.00173	CcSEcCtD
Regorafenib—Abdominal pain—Bupropion—obesity	0.000272	0.00173	CcSEcCtD
Regorafenib—Diarrhoea—Sibutramine—obesity	0.00027	0.00172	CcSEcCtD
Regorafenib—CYP2B6—digestive system—obesity	0.00027	0.00201	CbGeAlD
Regorafenib—Malnutrition—Topiramate—obesity	0.000269	0.00171	CcSEcCtD
Regorafenib—CYP2C9—digestive system—obesity	0.000267	0.00199	CbGeAlD
Regorafenib—Vomiting—Orlistat—obesity	0.000259	0.00165	CcSEcCtD
Regorafenib—CYP2B6—adrenal gland—obesity	0.000257	0.00191	CbGeAlD
Regorafenib—Rash—Orlistat—obesity	0.000257	0.00164	CcSEcCtD
Regorafenib—Dermatitis—Orlistat—obesity	0.000257	0.00164	CcSEcCtD
Regorafenib—CYP2C19—liver—obesity	0.000257	0.00191	CbGeAlD
Regorafenib—Headache—Orlistat—obesity	0.000256	0.00163	CcSEcCtD
Regorafenib—Tremor—Topiramate—obesity	0.000252	0.0016	CcSEcCtD
Regorafenib—Vomiting—Sibutramine—obesity	0.000251	0.0016	CcSEcCtD
Regorafenib—Rash—Sibutramine—obesity	0.000249	0.00158	CcSEcCtD
Regorafenib—Dermatitis—Sibutramine—obesity	0.000249	0.00158	CcSEcCtD
Regorafenib—CYP2C8—endocrine gland—obesity	0.000249	0.00185	CbGeAlD
Regorafenib—Anaemia—Topiramate—obesity	0.000248	0.00158	CcSEcCtD
Regorafenib—Headache—Sibutramine—obesity	0.000247	0.00157	CcSEcCtD
Regorafenib—Asthenia—Bupropion—obesity	0.000247	0.00157	CcSEcCtD
Regorafenib—Nausea—Orlistat—obesity	0.000242	0.00154	CcSEcCtD
Regorafenib—Leukopenia—Topiramate—obesity	0.00024	0.00153	CcSEcCtD
Regorafenib—ABCB1—islet of Langerhans—obesity	0.00024	0.00179	CbGeAlD
Regorafenib—Diarrhoea—Bupropion—obesity	0.000235	0.0015	CcSEcCtD
Regorafenib—Nausea—Sibutramine—obesity	0.000234	0.00149	CcSEcCtD
Regorafenib—Hypertension—Topiramate—obesity	0.000232	0.00148	CcSEcCtD
Regorafenib—Unspecified disorder of skin and subcutaneous tissue—Topiramate—obesity	0.000227	0.00145	CcSEcCtD
Regorafenib—ABCB1—respiratory system—obesity	0.000227	0.00169	CbGeAlD
Regorafenib—CYP2C8—liver—obesity	0.000224	0.00167	CbGeAlD
Regorafenib—Dry mouth—Topiramate—obesity	0.000224	0.00142	CcSEcCtD
Regorafenib—CYP2B6—endocrine gland—obesity	0.000223	0.00166	CbGeAlD
Regorafenib—CYP2C9—endocrine gland—obesity	0.000221	0.00164	CbGeAlD
Regorafenib—Vomiting—Bupropion—obesity	0.000219	0.00139	CcSEcCtD
Regorafenib—ABCG2—liver—obesity	0.000218	0.00162	CbGeAlD
Regorafenib—Infection—Topiramate—obesity	0.000218	0.00139	CcSEcCtD
Regorafenib—Rash—Bupropion—obesity	0.000217	0.00138	CcSEcCtD
Regorafenib—Dermatitis—Bupropion—obesity	0.000217	0.00138	CcSEcCtD
Regorafenib—Headache—Bupropion—obesity	0.000216	0.00137	CcSEcCtD
Regorafenib—Nervous system disorder—Topiramate—obesity	0.000215	0.00137	CcSEcCtD
Regorafenib—Thrombocytopenia—Topiramate—obesity	0.000215	0.00137	CcSEcCtD
Regorafenib—Skin disorder—Topiramate—obesity	0.000213	0.00136	CcSEcCtD
Regorafenib—Nausea—Bupropion—obesity	0.000204	0.0013	CcSEcCtD
Regorafenib—CYP3A4—digestive system—obesity	0.000204	0.00151	CbGeAlD
Regorafenib—CYP2B6—liver—obesity	0.000201	0.00149	CbGeAlD
Regorafenib—CYP2C9—liver—obesity	0.000199	0.00148	CbGeAlD
Regorafenib—Decreased appetite—Topiramate—obesity	0.000191	0.00121	CcSEcCtD
Regorafenib—ABCB1—adrenal cortex—obesity	0.00019	0.00142	CbGeAlD
Regorafenib—Gastrointestinal disorder—Topiramate—obesity	0.000189	0.0012	CcSEcCtD
Regorafenib—Fatigue—Topiramate—obesity	0.000189	0.0012	CcSEcCtD
Regorafenib—Pain—Topiramate—obesity	0.000187	0.00119	CcSEcCtD
Regorafenib—Gastrointestinal pain—Topiramate—obesity	0.000179	0.00114	CcSEcCtD
Regorafenib—ABCB1—cardiovascular system—obesity	0.000174	0.00129	CbGeAlD
Regorafenib—Body temperature increased—Topiramate—obesity	0.000173	0.0011	CcSEcCtD
Regorafenib—Abdominal pain—Topiramate—obesity	0.000173	0.0011	CcSEcCtD
Regorafenib—CYP3A4—endocrine gland—obesity	0.000168	0.00125	CbGeAlD
Regorafenib—Asthenia—Topiramate—obesity	0.000157	0.001	CcSEcCtD
Regorafenib—ABCB1—pituitary gland—obesity	0.000154	0.00114	CbGeAlD
Regorafenib—ABCB1—adipose tissue—obesity	0.000153	0.00114	CbGeAlD
Regorafenib—CYP3A4—liver—obesity	0.000152	0.00113	CbGeAlD
Regorafenib—Diarrhoea—Topiramate—obesity	0.00015	0.000955	CcSEcCtD
Regorafenib—ABCB1—digestive system—obesity	0.000144	0.00107	CbGeAlD
Regorafenib—Vomiting—Topiramate—obesity	0.000139	0.000887	CcSEcCtD
Regorafenib—Rash—Topiramate—obesity	0.000138	0.00088	CcSEcCtD
Regorafenib—Dermatitis—Topiramate—obesity	0.000138	0.000879	CcSEcCtD
Regorafenib—ABCB1—adrenal gland—obesity	0.000137	0.00102	CbGeAlD
Regorafenib—Headache—Topiramate—obesity	0.000137	0.000874	CcSEcCtD
Regorafenib—Nausea—Topiramate—obesity	0.00013	0.000829	CcSEcCtD
Regorafenib—ABCB1—endocrine gland—obesity	0.000119	0.000886	CbGeAlD
Regorafenib—ABCB1—liver—obesity	0.000107	0.000799	CbGeAlD
Regorafenib—ABCB1—Metabolism—GNAS—obesity	1.87e-06	6.9e-06	CbGpPWpGaD
Regorafenib—PDGFRA—Immune System—IL6—obesity	1.86e-06	6.89e-06	CbGpPWpGaD
Regorafenib—BRAF—Signaling Pathways—MYC—obesity	1.86e-06	6.88e-06	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—DCN—obesity	1.86e-06	6.87e-06	CbGpPWpGaD
Regorafenib—BRAF—Signaling Pathways—TGFB1—obesity	1.86e-06	6.86e-06	CbGpPWpGaD
Regorafenib—FGFR2—Signaling Pathways—STAT3—obesity	1.86e-06	6.86e-06	CbGpPWpGaD
Regorafenib—KDR—Signaling Pathways—PIK3CA—obesity	1.85e-06	6.86e-06	CbGpPWpGaD
Regorafenib—ABCG2—Metabolism—PTGS2—obesity	1.85e-06	6.85e-06	CbGpPWpGaD
Regorafenib—FGFR2—Disease—IL6—obesity	1.85e-06	6.84e-06	CbGpPWpGaD
Regorafenib—RAF1—Signaling by GPCR—PIK3CA—obesity	1.85e-06	6.84e-06	CbGpPWpGaD
Regorafenib—FGFR2—Immune System—AKT1—obesity	1.85e-06	6.84e-06	CbGpPWpGaD
Regorafenib—ABL1—Immune System—PIK3CA—obesity	1.85e-06	6.83e-06	CbGpPWpGaD
Regorafenib—BRAF—Disease—AKT1—obesity	1.84e-06	6.81e-06	CbGpPWpGaD
Regorafenib—RAF1—Disease—MYC—obesity	1.84e-06	6.8e-06	CbGpPWpGaD
Regorafenib—RAF1—Disease—TGFB1—obesity	1.83e-06	6.78e-06	CbGpPWpGaD
Regorafenib—ABCB1—Metabolism—APOB—obesity	1.83e-06	6.75e-06	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—STAT3—obesity	1.82e-06	6.74e-06	CbGpPWpGaD
Regorafenib—KIT—Disease—IL6—obesity	1.82e-06	6.72e-06	CbGpPWpGaD
Regorafenib—KIT—Immune System—AKT1—obesity	1.82e-06	6.72e-06	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism—COMT—obesity	1.81e-06	6.71e-06	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—CPT1A—obesity	1.81e-06	6.68e-06	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism—MTHFR—obesity	1.8e-06	6.67e-06	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—MTOR—obesity	1.79e-06	6.63e-06	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—PIK3CB—obesity	1.79e-06	6.63e-06	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism—GNB3—obesity	1.79e-06	6.62e-06	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism—PPARGC1A—obesity	1.79e-06	6.62e-06	CbGpPWpGaD
Regorafenib—CYP2B6—Metabolism—PIK3CG—obesity	1.79e-06	6.61e-06	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism—LPL—obesity	1.79e-06	6.61e-06	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism—HMOX1—obesity	1.78e-06	6.59e-06	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—NAMPT—obesity	1.77e-06	6.55e-06	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism—PPARA—obesity	1.77e-06	6.54e-06	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—LIPC—obesity	1.76e-06	6.51e-06	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—GCK—obesity	1.76e-06	6.51e-06	CbGpPWpGaD
Regorafenib—PDGFRB—Disease—PIK3CA—obesity	1.75e-06	6.47e-06	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—APOC3—obesity	1.75e-06	6.47e-06	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—MMP9—obesity	1.75e-06	6.46e-06	CbGpPWpGaD
Regorafenib—ABCB1—Metabolism—LPL—obesity	1.74e-06	6.45e-06	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism—GPX1—obesity	1.74e-06	6.45e-06	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism—GNAS—obesity	1.74e-06	6.44e-06	CbGpPWpGaD
Regorafenib—NTRK1—Signaling Pathways—IL6—obesity	1.74e-06	6.42e-06	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—STAT3—obesity	1.73e-06	6.4e-06	CbGpPWpGaD
Regorafenib—CYP2B6—Metabolism—PPARG—obesity	1.73e-06	6.38e-06	CbGpPWpGaD
Regorafenib—FGFR1—Disease—IL6—obesity	1.73e-06	6.38e-06	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—STAT3—obesity	1.73e-06	6.38e-06	CbGpPWpGaD
Regorafenib—FGFR2—Signaling Pathways—MYC—obesity	1.72e-06	6.38e-06	CbGpPWpGaD
Regorafenib—FGFR1—Immune System—AKT1—obesity	1.72e-06	6.37e-06	CbGpPWpGaD
Regorafenib—PDGFRA—Disease—IL6—obesity	1.72e-06	6.36e-06	CbGpPWpGaD
Regorafenib—FGFR2—Signaling Pathways—TGFB1—obesity	1.72e-06	6.36e-06	CbGpPWpGaD
Regorafenib—PDGFRA—Immune System—AKT1—obesity	1.72e-06	6.36e-06	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism—AGT—obesity	1.71e-06	6.33e-06	CbGpPWpGaD
Regorafenib—FGFR2—Disease—AKT1—obesity	1.71e-06	6.31e-06	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism—APOB—obesity	1.71e-06	6.31e-06	CbGpPWpGaD
Regorafenib—CYP2B6—Metabolism—POMC—obesity	1.7e-06	6.3e-06	CbGpPWpGaD
Regorafenib—ABCB1—Metabolism—GPX1—obesity	1.7e-06	6.29e-06	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—MAPK8—obesity	1.7e-06	6.29e-06	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—CETP—obesity	1.7e-06	6.28e-06	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism—CD36—obesity	1.7e-06	6.28e-06	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—MYC—obesity	1.69e-06	6.26e-06	CbGpPWpGaD
Regorafenib—CYP2B6—Metabolism—INS—obesity	1.69e-06	6.26e-06	CbGpPWpGaD
Regorafenib—RAF1—Immune System—PIK3CA—obesity	1.69e-06	6.25e-06	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—TGFB1—obesity	1.69e-06	6.25e-06	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—SDC1—obesity	1.68e-06	6.21e-06	CbGpPWpGaD
Regorafenib—PDGFRB—Immune System—IL6—obesity	1.68e-06	6.21e-06	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism—APOE—obesity	1.68e-06	6.21e-06	CbGpPWpGaD
Regorafenib—KIT—Disease—AKT1—obesity	1.68e-06	6.2e-06	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism—CAV1—obesity	1.66e-06	6.15e-06	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism—APOA1—obesity	1.66e-06	6.13e-06	CbGpPWpGaD
Regorafenib—ABCB1—Metabolism—CD36—obesity	1.66e-06	6.13e-06	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—AKR1C3—obesity	1.65e-06	6.11e-06	CbGpPWpGaD
Regorafenib—KDR—Signaling Pathways—IL6—obesity	1.64e-06	6.07e-06	CbGpPWpGaD
Regorafenib—RAF1—Signaling by GPCR—IL6—obesity	1.64e-06	6.06e-06	CbGpPWpGaD
Regorafenib—ABL1—Immune System—IL6—obesity	1.64e-06	6.05e-06	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism—LPL—obesity	1.63e-06	6.02e-06	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—SCARB1—obesity	1.63e-06	6.02e-06	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism—MTHFR—obesity	1.61e-06	5.95e-06	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—MYC—obesity	1.61e-06	5.94e-06	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—TGFB1—obesity	1.6e-06	5.93e-06	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—MYC—obesity	1.6e-06	5.93e-06	CbGpPWpGaD
Regorafenib—NTRK1—Signaling Pathways—AKT1—obesity	1.6e-06	5.93e-06	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—TGFB1—obesity	1.6e-06	5.91e-06	CbGpPWpGaD
Regorafenib—MAPK11—Signaling Pathways—PIK3CA—obesity	1.59e-06	5.9e-06	CbGpPWpGaD
Regorafenib—FGFR1—Disease—AKT1—obesity	1.59e-06	5.89e-06	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism—GPX1—obesity	1.59e-06	5.88e-06	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—obesity	1.59e-06	5.87e-06	CbGpPWpGaD
Regorafenib—PDGFRA—Disease—AKT1—obesity	1.59e-06	5.87e-06	CbGpPWpGaD
Regorafenib—BRAF—Signaling Pathways—PIK3CA—obesity	1.58e-06	5.84e-06	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—SREBF1—obesity	1.58e-06	5.84e-06	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism—PPARA—obesity	1.58e-06	5.84e-06	CbGpPWpGaD
Regorafenib—CYP2B6—Metabolism—PIK3CD—obesity	1.57e-06	5.82e-06	CbGpPWpGaD
Regorafenib—ABCB1—Metabolism—MTHFR—obesity	1.57e-06	5.81e-06	CbGpPWpGaD
Regorafenib—RAF1—Disease—PIK3CA—obesity	1.56e-06	5.77e-06	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—MMP9—obesity	1.56e-06	5.76e-06	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—STAT3—obesity	1.55e-06	5.75e-06	CbGpPWpGaD
Regorafenib—CYP2B6—Metabolism—ALB—obesity	1.55e-06	5.74e-06	CbGpPWpGaD
Regorafenib—PDGFRB—Disease—IL6—obesity	1.55e-06	5.73e-06	CbGpPWpGaD
Regorafenib—PDGFRB—Immune System—AKT1—obesity	1.55e-06	5.73e-06	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism—CD36—obesity	1.55e-06	5.72e-06	CbGpPWpGaD
Regorafenib—ABCB1—Metabolism—PPARA—obesity	1.54e-06	5.7e-06	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—GOT2—obesity	1.54e-06	5.68e-06	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism—AGT—obesity	1.53e-06	5.65e-06	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—MAPK8—obesity	1.52e-06	5.6e-06	CbGpPWpGaD
Regorafenib—KDR—Signaling Pathways—AKT1—obesity	1.51e-06	5.6e-06	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism—PIK3CG—obesity	1.51e-06	5.6e-06	CbGpPWpGaD
Regorafenib—RAF1—Signaling by GPCR—AKT1—obesity	1.51e-06	5.59e-06	CbGpPWpGaD
Regorafenib—ABL1—Immune System—AKT1—obesity	1.51e-06	5.58e-06	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—FASN—obesity	1.5e-06	5.56e-06	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism—APOE—obesity	1.5e-06	5.54e-06	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—BCHE—obesity	1.5e-06	5.54e-06	CbGpPWpGaD
Regorafenib—RAF1—Immune System—IL6—obesity	1.5e-06	5.53e-06	CbGpPWpGaD
Regorafenib—ABCB1—Metabolism—AGT—obesity	1.49e-06	5.52e-06	CbGpPWpGaD
Regorafenib—CYP2B6—Metabolism—PIK3R1—obesity	1.48e-06	5.49e-06	CbGpPWpGaD
Regorafenib—CYP2B6—Metabolism—NOS3—obesity	1.48e-06	5.49e-06	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism—CAV1—obesity	1.48e-06	5.49e-06	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism—APOA1—obesity	1.48e-06	5.48e-06	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism—MTHFR—obesity	1.47e-06	5.42e-06	CbGpPWpGaD
Regorafenib—FGFR2—Signaling Pathways—PIK3CA—obesity	1.46e-06	5.41e-06	CbGpPWpGaD
Regorafenib—ABCB1—Metabolism—APOE—obesity	1.46e-06	5.41e-06	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism—PPARG—obesity	1.46e-06	5.4e-06	CbGpPWpGaD
Regorafenib—ABCB1—Metabolism—CAV1—obesity	1.45e-06	5.36e-06	CbGpPWpGaD
Regorafenib—ABCB1—Metabolism—APOA1—obesity	1.45e-06	5.34e-06	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—CYP2E1—obesity	1.44e-06	5.34e-06	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—MYC—obesity	1.44e-06	5.34e-06	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism—POMC—obesity	1.44e-06	5.33e-06	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—TGFB1—obesity	1.44e-06	5.33e-06	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism—PPARA—obesity	1.44e-06	5.32e-06	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—PIK3CA—obesity	1.44e-06	5.32e-06	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism—INS—obesity	1.43e-06	5.3e-06	CbGpPWpGaD
Regorafenib—PDGFRB—Disease—AKT1—obesity	1.43e-06	5.29e-06	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—NQO1—obesity	1.43e-06	5.28e-06	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—obesity	1.42e-06	5.24e-06	CbGpPWpGaD
Regorafenib—MAPK11—Signaling Pathways—IL6—obesity	1.41e-06	5.22e-06	CbGpPWpGaD
Regorafenib—BRAF—Signaling Pathways—IL6—obesity	1.4e-06	5.17e-06	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism—AGT—obesity	1.39e-06	5.15e-06	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—STAT3—obesity	1.39e-06	5.12e-06	CbGpPWpGaD
Regorafenib—RAF1—Disease—IL6—obesity	1.38e-06	5.11e-06	CbGpPWpGaD
Regorafenib—RAF1—Immune System—AKT1—obesity	1.38e-06	5.11e-06	CbGpPWpGaD
Regorafenib—CYP2B6—Metabolism—PIK3CB—obesity	1.37e-06	5.07e-06	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—GCG—obesity	1.37e-06	5.06e-06	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—SLC2A4—obesity	1.37e-06	5.06e-06	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism—APOE—obesity	1.37e-06	5.05e-06	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—PIK3CA—obesity	1.36e-06	5.05e-06	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—PIK3CA—obesity	1.36e-06	5.03e-06	CbGpPWpGaD
Regorafenib—CYP2B6—Metabolism—PTGS2—obesity	1.36e-06	5.02e-06	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism—CAV1—obesity	1.35e-06	5e-06	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism—PIK3CG—obesity	1.35e-06	5e-06	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—CYCS—obesity	1.35e-06	5e-06	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism—APOA1—obesity	1.35e-06	4.99e-06	CbGpPWpGaD
Regorafenib—UGT1A9—Metabolism—PIK3CA—obesity	1.34e-06	4.97e-06	CbGpPWpGaD
Regorafenib—UGT1A1—Metabolism—PIK3CA—obesity	1.34e-06	4.97e-06	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism—PIK3CD—obesity	1.33e-06	4.92e-06	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—GOT1—obesity	1.33e-06	4.9e-06	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—GGT1—obesity	1.33e-06	4.9e-06	CbGpPWpGaD
Regorafenib—ABCB1—Metabolism—PIK3CG—obesity	1.32e-06	4.88e-06	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism—ALB—obesity	1.31e-06	4.86e-06	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—NCOA1—obesity	1.31e-06	4.83e-06	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism—PPARG—obesity	1.3e-06	4.82e-06	CbGpPWpGaD
Regorafenib—MAPK11—Signaling Pathways—AKT1—obesity	1.3e-06	4.82e-06	CbGpPWpGaD
Regorafenib—FGFR2—Signaling Pathways—IL6—obesity	1.3e-06	4.79e-06	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—obesity	1.29e-06	4.78e-06	CbGpPWpGaD
Regorafenib—BRAF—Signaling Pathways—AKT1—obesity	1.29e-06	4.77e-06	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—STK11—obesity	1.29e-06	4.76e-06	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—CYP19A1—obesity	1.29e-06	4.76e-06	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—MYC—obesity	1.29e-06	4.76e-06	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism—POMC—obesity	1.29e-06	4.76e-06	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—TGFB1—obesity	1.28e-06	4.75e-06	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism—INS—obesity	1.28e-06	4.73e-06	CbGpPWpGaD
Regorafenib—RAF1—Disease—AKT1—obesity	1.27e-06	4.71e-06	CbGpPWpGaD
Regorafenib—ABCB1—Metabolism—PPARG—obesity	1.27e-06	4.71e-06	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—IL6—obesity	1.27e-06	4.71e-06	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism—PIK3R1—obesity	1.26e-06	4.65e-06	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism—NOS3—obesity	1.26e-06	4.65e-06	CbGpPWpGaD
Regorafenib—ABCB1—Metabolism—POMC—obesity	1.26e-06	4.64e-06	CbGpPWpGaD
Regorafenib—ABCB1—Metabolism—INS—obesity	1.25e-06	4.62e-06	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism—PIK3CG—obesity	1.23e-06	4.56e-06	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—PIK3CA—obesity	1.23e-06	4.53e-06	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—IL6—obesity	1.21e-06	4.47e-06	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—IL6—obesity	1.21e-06	4.46e-06	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—COMT—obesity	1.2e-06	4.43e-06	CbGpPWpGaD
Regorafenib—FGFR2—Signaling Pathways—AKT1—obesity	1.2e-06	4.42e-06	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism—PPARG—obesity	1.19e-06	4.4e-06	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism—PIK3CD—obesity	1.19e-06	4.39e-06	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—PPARGC1A—obesity	1.18e-06	4.36e-06	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—GNB3—obesity	1.18e-06	4.36e-06	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—HMOX1—obesity	1.17e-06	4.34e-06	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—AKT1—obesity	1.17e-06	4.34e-06	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism—POMC—obesity	1.17e-06	4.34e-06	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism—ALB—obesity	1.17e-06	4.34e-06	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism—INS—obesity	1.17e-06	4.31e-06	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism—PIK3CB—obesity	1.16e-06	4.29e-06	CbGpPWpGaD
Regorafenib—ABCB1—Metabolism—PIK3CD—obesity	1.16e-06	4.29e-06	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism—PTGS2—obesity	1.15e-06	4.25e-06	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—GNAS—obesity	1.15e-06	4.25e-06	CbGpPWpGaD
Regorafenib—ABCB1—Metabolism—ALB—obesity	1.14e-06	4.23e-06	CbGpPWpGaD
Regorafenib—ABCG2—Metabolism—PIK3CA—obesity	1.14e-06	4.22e-06	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—APOB—obesity	1.13e-06	4.16e-06	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism—PIK3R1—obesity	1.12e-06	4.15e-06	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism—NOS3—obesity	1.12e-06	4.15e-06	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—AKT1—obesity	1.11e-06	4.12e-06	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—AKT1—obesity	1.11e-06	4.11e-06	CbGpPWpGaD
Regorafenib—UGT1A1—Metabolism—AKT1—obesity	1.1e-06	4.06e-06	CbGpPWpGaD
Regorafenib—UGT1A9—Metabolism—AKT1—obesity	1.1e-06	4.06e-06	CbGpPWpGaD
Regorafenib—ABCB1—Metabolism—NOS3—obesity	1.1e-06	4.05e-06	CbGpPWpGaD
Regorafenib—ABCB1—Metabolism—PIK3R1—obesity	1.1e-06	4.05e-06	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—PIK3CA—obesity	1.09e-06	4.04e-06	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—IL6—obesity	1.09e-06	4.01e-06	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism—PIK3CD—obesity	1.08e-06	4.01e-06	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—LPL—obesity	1.07e-06	3.97e-06	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism—ALB—obesity	1.07e-06	3.96e-06	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—GPX1—obesity	1.05e-06	3.88e-06	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism—PIK3CB—obesity	1.04e-06	3.83e-06	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism—PTGS2—obesity	1.03e-06	3.8e-06	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism—PIK3R1—obesity	1.02e-06	3.78e-06	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism—NOS3—obesity	1.02e-06	3.78e-06	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—CD36—obesity	1.02e-06	3.78e-06	CbGpPWpGaD
Regorafenib—ABCB1—Metabolism—PIK3CB—obesity	1.01e-06	3.74e-06	CbGpPWpGaD
Regorafenib—ABCB1—Metabolism—PTGS2—obesity	1e-06	3.7e-06	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—AKT1—obesity	1e-06	3.7e-06	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—IL6—obesity	9.68e-07	3.58e-06	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—MTHFR—obesity	9.67e-07	3.58e-06	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—PPARA—obesity	9.49e-07	3.51e-06	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism—PIK3CB—obesity	9.44e-07	3.49e-06	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism—PTGS2—obesity	9.36e-07	3.46e-06	CbGpPWpGaD
Regorafenib—ABCG2—Metabolism—AKT1—obesity	9.31e-07	3.44e-06	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—AGT—obesity	9.19e-07	3.4e-06	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—APOE—obesity	9.01e-07	3.33e-06	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—AKT1—obesity	8.93e-07	3.3e-06	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—CAV1—obesity	8.92e-07	3.3e-06	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—APOA1—obesity	8.9e-07	3.29e-06	CbGpPWpGaD
Regorafenib—CYP2B6—Metabolism—PIK3CA—obesity	8.36e-07	3.09e-06	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—PIK3CG—obesity	8.13e-07	3.01e-06	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—PPARG—obesity	7.84e-07	2.9e-06	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—POMC—obesity	7.74e-07	2.86e-06	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—INS—obesity	7.69e-07	2.85e-06	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—PIK3CD—obesity	7.15e-07	2.64e-06	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism—PIK3CA—obesity	7.07e-07	2.62e-06	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—ALB—obesity	7.05e-07	2.61e-06	CbGpPWpGaD
Regorafenib—CYP2B6—Metabolism—AKT1—obesity	6.83e-07	2.52e-06	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—PIK3R1—obesity	6.75e-07	2.5e-06	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—NOS3—obesity	6.75e-07	2.5e-06	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism—PIK3CA—obesity	6.31e-07	2.33e-06	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—PIK3CB—obesity	6.23e-07	2.3e-06	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—PTGS2—obesity	6.17e-07	2.28e-06	CbGpPWpGaD
Regorafenib—ABCB1—Metabolism—PIK3CA—obesity	6.16e-07	2.28e-06	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism—AKT1—obesity	5.78e-07	2.14e-06	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism—PIK3CA—obesity	5.76e-07	2.13e-06	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism—AKT1—obesity	5.16e-07	1.91e-06	CbGpPWpGaD
Regorafenib—ABCB1—Metabolism—AKT1—obesity	5.03e-07	1.86e-06	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism—AKT1—obesity	4.7e-07	1.74e-06	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—PIK3CA—obesity	3.8e-07	1.4e-06	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—AKT1—obesity	3.1e-07	1.15e-06	CbGpPWpGaD
